{{expand|time=2017-12-24T17:23:18+00:00}}
{{Selfref|關於一團命名為'''AKB48'''的日本歌藝團體，請見[[AKB48|AKB48]]。}}

{{Drugbox
| IUPAC_name = 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide 
| image = APINACA.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = Temporary Class Drug (NZ), illegal in Japan
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 1345973-53-6
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
| smiles = C3C4CC2CC3CC(C4)(C2)NC(=O)c(nn1CCCCC)c5c1cccc5

<!--Chemical data-->
| C=23 | H=31 | N=3 | O=1 
| molecular_weight = 365.510 g/mol
}}

'''AKB48'''（'''APINACA''', '''N-(1-金刚烷)-1-戊基-1H-吲唑-3-甲酰胺'''）是一种潜在的[[大麻素|大麻素]][[受体|受体]][[激动剂|激动剂]]。此前它从未在科学界或专利文献中被报道过，2012年3月在日本的实验室中作为[[合成大麻|合成大麻]]混合烟的原料被识别出来<ref>{{cite journal|coauthors=Kawamura, Maiko; Kikura-Hanajiri, Ruri; Goda, Yukihiro|title=Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products|journal=Forensic Toxicology|date=2012-04-10|volume=30|issue=2|pages=114–125|doi=10.1007/s11419-012-0136-7|last=Uchiyama|first=Nahoko}}</ref>。结构上它类似于专利号为[http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2003035005 WO 2003/035005]{{Wayback|url=http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2003035005 |date=20131204000422 }}的大麻素化合物，除了吲唑1位上引入了一条戊烷基链，因而APINACA应属于该专利所涵盖的范围，尽管尚未作为实例得到确认。APINACA于2012年在日本被宣布为非法药物<ref>{{Cite web |url=http://members.wto.org/crnattachments/2012/tbt/JPN/12_1575_00_e.pdf |title=Designation of “Shitei Yakubutsu” (designated substances) based on the provision of the Pharmaceutical Affairs Law (1960, Law No.145) |accessdate=2012-07-17 |archive-date=2019-02-15 |archive-url=https://web.archive.org/web/20190215111916/https://members.wto.org/crnattachments/2012/tbt/JPN/12_1575_00_e.pdf |dead-url=no }}</ref>，从2012年7月13日起作为临时类毒品在新西兰被禁止。<ref>{{Cite web |url=http://www.dia.govt.nz/MSOS118/On-Line/NZGazette.nsf/6cee7698a9bbc7cfcc256d510059ed0b/1800482ea20e00f8cc257a32005ae9f8!OpenDocument |title=Temporary Class Drug Notice, 05 July 2012. NZ Department of Internal Affairs. |accessdate=2012-07-17 |archive-date=2013-06-15 |archive-url=https://web.archive.org/web/20130615155240/http://www.dia.govt.nz/MSOS118/On-Line/NZGazette.nsf/6cee7698a9bbc7cfcc256d510059ed0b/1800482ea20e00f8cc257a32005ae9f8!OpenDocument |dead-url=no }}</ref>

== 参见 ==
* [[大麻素|大麻素]]
* [[精神药品|精神药品]]

== 参考文献 ==
{{reflist}}

[[Category:精神药物|Category:精神药物]]